Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection
Abstract Background Resistant staphylococcal organisms remain a serious problem in the treatment of periprosthetic joint infection (PJI). Higher failure rates have been reported when vancomycin was used. The purpose of this study was to assess the clinical dosage, effect, and safety of daptomycin in...
Main Authors: | Yu-Jui Chang, Mel S. Lee, Chen-Hsiang Lee, Po-Chun Lin, Feng-Chih Kuo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-017-2842-6 |
Similar Items
-
Daptomycin in the treatment of prosthetic joint infection by Enterococcus faecalis: safety and efficacy of high-dose and prolonged therapy
by: José Ramón Yuste, et al.
Published: (2014-10-01) -
Self-enhanced targeted delivery of a cell wall– and membrane-active antibiotics, daptomycin, against staphylococcal pneumonia
by: Hong Jiang, et al.
Published: (2016-07-01) -
Daptomycin in the Treatment of Diabetic Foot Infections without Osteomyelitis; A Multicenter Study
by: Meltem IŞIKGÖZ TAŞBAKAN, et al.
Published: (2017-12-01) -
Role of Daptomycin in the Induction and Persistence of the Viable but Non-Culturable State of Staphylococcus Aureus Biofilms
by: Sonia Pasquaroli, et al.
Published: (2014-09-01) -
Fitness Cost of Daptomycin-Resistant Staphylococcus aureus Obtained from in Vitro Daptomycin Selection Pressure
by: Shuguang Li, et al.
Published: (2017-11-01)